CASP4 expression tracks fibrosis severity in metabolic dysfunction-associated steatotic liver disease and CASP4-targeting siRNA reduces inflammatory hepatocyte injury

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) involves heterogeneous inflammatory and fibrotic states. We investigated the relationship between CASP4 expression, MASLD severity, and fatty-acid-associated hepatocyte injury. Methods Discovery bulk RNA sequencing included 216 liver samples spanning fibrosis stages F0–F4 (GSE135251), with candidate prioritization informed by an independent 98-biopsy NAFL/NASH cohort (GSE167523). Single-nucleus datasets provided cell-type localization using participant-level summaries (GSE244832) and evaluation across 48 control, MASL, early-MASH, and advanced-MASH participants (GSE289173); an unpaired chromatin-accessibility cohort provided molecular context (GSE281367). CASP4-targeting siRNA was tested in fatty-acid-exposed HepG2 and Huh7 cells using viability, membrane-injury, inflammatory, and apoptosis-associated readouts. Results CASP4 expression increased with fibrosis stage in discovery tissue (β = 0.0800, FDR = 1.41 × 10 −8 ) and was higher in external NASH than NAFL biopsies (β = 0.2146, FDR = 1.06 × 10 −4 ). The hepatocyte ordered-stage coefficient was positive (β = 0.02394, FDR = 0.0373), with weaker support after sex adjustment (FDR = 0.0647) and a nonsignificant categorical-stage test. The largest within-state estimate was observed in pericentral hepatocytes. In HepG2 and Huh7 cells, oleic acid/palmitic acid exposure increased CASP4 mRNA and injury. The selected CASP4-targeting siRNA improved viability and reduced LDH release; in HepG2 cells it also reduced inflammatory outputs, Annexin V positivity, and cleaved caspase-3 fluorescence. Conclusion These findings link severity-associated CASP4 expression to an siRNA-associated inflammatory injury phenotype in fatty-acid-exposed hepatocyte-derived cells.

Authors

Institutions

Publication Details

Journal
Frontiers in Cell and Developmental Biology
Published
2026-11-18
DOI
https://doi.org/10.3389/fcell.2026.1996421
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

CASP4 expression tracks fibrosis severity in metabolic dysfunction-associated steatotic liver disease and CASP4-targeting siRNA reduces inflammatory hepatocyte injury

Feng Liang, Min Shi, Jie Gou, Wenjuan Wang et al.
5 links
Frontiers in Cell and Developmental Biology
Liver Disease Diagnosis and Treatment
article

CASP4 expression tracks fibrosis severity in metabolic dysfunction-associated steatotic liver disease and CASP4-targeting siRNA reduces inflammatory hepatocyte injury

Feng Liang, Min Shi, Jie Gou, Wenjuan Wang, Wan’e Wang, Yingyu Xie
article en

Abstract

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) involves heterogeneous inflammatory and fibrotic states. We investigated the relationship between CASP4 expression, MASLD severity, and fatty-acid-associated hepatocyte injury. Methods Discovery bulk RNA sequencing included 216 liver samples spanning fibrosis stages F0–F4 (GSE135251), with candidate prioritization informed by an independent 98-biopsy NAFL/NASH cohort (GSE167523). Single-nucleus datasets provided cell-type localization using participant-level summaries (GSE244832) and evaluation across 48 control, MASL, early-MASH, and advanced-MASH participants (GSE289173); an unpaired chromatin-accessibility cohort provided molecular context (GSE281367). CASP4-targeting siRNA was tested in fatty-acid-exposed HepG2 and Huh7 cells using viability, membrane-injury, inflammatory, and apoptosis-associated readouts. Results CASP4 expression increased with fibrosis stage in discovery tissue (β = 0.0800, FDR = 1.41 × 10 −8 ) and was higher in external NASH than NAFL biopsies (β = 0.2146, FDR = 1.06 × 10 −4 ). The hepatocyte ordered-stage coefficient was positive (β = 0.02394, FDR = 0.0373), with weaker support after sex adjustment (FDR = 0.0647) and a nonsignificant categorical-stage test. The largest within-state estimate was observed in pericentral hepatocytes. In HepG2 and Huh7 cells, oleic acid/palmitic acid exposure increased CASP4 mRNA and injury. The selected CASP4-targeting siRNA improved viability and reduced LDH release; in HepG2 cells it also reduced inflammatory outputs, Annexin V positivity, and cleaved caspase-3 fluorescence. Conclusion These findings link severity-associated CASP4 expression to an siRNA-associated inflammatory injury phenotype in fatty-acid-exposed hepatocyte-derived cells.

Frontiers in Cell and Developmental BiologyVol. 14
Huaian First People’s Hospital (CN), Jinhua Academy of Agricultural Sciences (CN), Second People’s Hospital of Huai’an (CN), Huai'an City Fourth People's Hospital (CN), Jinhua Central Hospital (CN), Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University (CN), Zhejiang University (CN), Nanjing Medical University (CN)
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon